[Cefoxitin and ESBL]

Med Mal Infect. 2012 Mar;42(3):126-8. doi: 10.1016/j.medmal.2012.01.004. Epub 2012 Feb 16.
[Article in French]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy
  • Bacteremia / microbiology
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism*
  • Catheter-Related Infections / complications
  • Catheter-Related Infections / drug therapy*
  • Catheter-Related Infections / microbiology
  • Cefoxitin / pharmacology
  • Cefoxitin / therapeutic use*
  • Cross Infection / drug therapy*
  • Cross Infection / microbiology
  • Diarrhea / complications
  • Diarrhea / microbiology
  • Drug Resistance, Multiple, Bacterial / genetics
  • Drug Therapy, Combination
  • Enterococcus faecalis / drug effects
  • Glycopeptides / pharmacology
  • Humans
  • Klebsiella Infections / complications
  • Klebsiella Infections / drug therapy*
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / drug effects*
  • Klebsiella pneumoniae / enzymology
  • Klebsiella pneumoniae / genetics
  • Klebsiella pneumoniae / isolation & purification
  • Male
  • Pancreatic Neoplasms / surgery
  • Pneumonia, Bacterial / complications
  • Pneumonia, Bacterial / drug therapy*
  • Pneumonia, Bacterial / microbiology
  • Postoperative Complications / drug therapy
  • Postoperative Complications / microbiology
  • Prostatitis / complications
  • Prostatitis / drug therapy
  • Prostatitis / microbiology
  • Substrate Specificity
  • Urinary Catheterization / adverse effects
  • beta-Lactam Resistance*
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Glycopeptides
  • Cefoxitin
  • beta-Lactamases